← Back to Search

Device

tDCS + Cognitive Training for Breast Cancer Survivors

N/A
Waitlist Available
Led By James Root, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether electrical stimulation can help improve memory in breast cancer survivors.

Who is the study for?
This trial is for breast cancer survivors aged 40-65 who finished chemotherapy at least six months ago, have no current evidence of disease, and may or may not be on endocrine therapy. They should self-report memory or cognitive issues post-treatment and must understand English. Excluded are those with pacemakers, neurological illnesses, pregnancy/breastfeeding status, schizophrenia, bipolar disorder, untreated depression/anxiety, or a history of CNS cancer.Check my eligibility
What is being tested?
The study tests the feasibility of using transcranial direct current stimulation (tDCS) alongside cognitive training to help improve memory in breast cancer survivors. It's a pilot study aimed at determining if this approach can be part of memory rehabilitation.See study design
What are the potential side effects?
While tDCS is generally considered safe with minimal side effects such as mild tingling or itching under the electrode site during treatment; headache and fatigue might occur but typically resolve shortly after sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
number of subjects recruited

Side effects data

From 2018 Phase 2 trial • 54 Patients • NCT01726673
3%
Myasthenia Gravis
3%
back pain flair up
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS + Robotic Arm Therapy
tDCS Sham + Robotic Arm Therapy

Trial Design

1Treatment groups
Experimental Treatment
Group I: tDCS with cognitive trainingExperimental Treatment2 Interventions
We will collect: 1) self-reported demographic information (~5 min) 2) cognitive functioning data (PAOFI) at session 1 and session 4 (~10min) [60]; 3) behavioral data and EEG data from the tDCS stimulation task for each session (downloaded by investigators); 4) patient feedback on their experience with tDCS (tDCS Patient Experience Questionnaire (tPEQ)) for each session (~5 min); 5) tDCS accrual and session completion rates at the completion of treatment and 6) Brunoni Adverse Events Questionnaire (~5 min)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation (tDCS)
2016
Completed Phase 2
~2100
Questionnaires
2013
Completed Phase 2
~3030

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,928 Previous Clinical Trials
591,790 Total Patients Enrolled
203 Trials studying Breast Cancer
95,169 Patients Enrolled for Breast Cancer
James Root, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
2 Previous Clinical Trials
506 Total Patients Enrolled

Media Library

tDCS (Device) Clinical Trial Eligibility Overview. Trial Name: NCT02726763 — N/A
Breast Cancer Research Study Groups: tDCS with cognitive training
Breast Cancer Clinical Trial 2023: tDCS Highlights & Side Effects. Trial Name: NCT02726763 — N/A
tDCS (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02726763 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals over 70 years old considered eligible for this medical experiment?

"This research study is seeking participants of an age bracket between 40 and 65 years old."

Answered by AI

To whom is enrollment for this trial open?

"This trial is recruiting 18 participants, aged 40 to 65 years old with a history of breast cancer. Eligible individuals must have undergone chemotherapy and completed the treatment at least six months prior, accompanied by no present evidence of disease. Furthermore, these patients ought to be able to read English, provide consenting cognizancely as judged by an investigator or professional; additionally they should respond affirmatively when prompted about whether their mental acuity has declined since finishing breast cancer treatments and if this decline makes it hard for them professionally or domestically."

Answered by AI

Is recruitment open for this medical experiment?

"The clinical trial data available on clinicaltrials.gov shows that this study is no longer actively recruiting participants, with the first posting date being March 1st 2016 and most recent update taking place April 19th 2022. However, there are currently 7 alternative trials actively searching for candidates to enrol in their research efforts."

Answered by AI
~2 spots leftby Mar 2025